Projects per year
Abstract / Description of output
Trypanosomatid parasites cause diseases in humans and livestock. It was reported that partial inhibition of the vacuolar ATPase (V-ATPase) affects dependence of Trypanosoma brucei on its mitochondrial genome (kDNA), a target of the anti-trypanosomatid drug isometamidium. Here we report that V-ATPase inhibition with bafilomycin A1 (BafA) provides partial resistance to genetic knockdown of mitochondrial gene expression. BafA does not promote long-term survival after kDNA loss, but in its presence, isometamidium causes less damage to kDNA.
Original language | English |
---|---|
Number of pages | 7 |
Journal | Antimicrobial Agents and Chemotherapy |
Volume | 62 |
Issue number | 9 |
Early online date | 18 Jun 2018 |
DOIs | |
Publication status | Published - 27 Aug 2018 |
Keywords / Materials (for Non-textual outputs)
- F1Fo-ATPase
- RNA editing
- Trypanosoma
- V-ATPase
- bafilomycin
- kDNA
- kinetoplast
- mitochondria
- vacuoles
Fingerprint
Dive into the research topics of 'Pharmacological Inhibition of the Vacuolar ATPase in Bloodstream-Form Trypanosoma brucei Rescues Genetic Knockdown of Mitochondrial Gene Expression'. Together they form a unique fingerprint.Projects
- 1 Finished
Profiles
-
Achim Schnaufer
- School of Biological Sciences - Personal Chair of Parasite and Mitochondrial Biology
Person: Academic: Research Active